MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.36
0.02 (6.97%)
▲
5d:
+15.92%
30d:
+24.86%
90d:
-74.09%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called MDCX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MDCX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MDCX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.36, which is considered extended relative to its 30-day fair value range of $0.29 to $0.34.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.39. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1484.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.39. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1484.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.29 -
$0.34
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+5.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.0%)
- BULLISH: Trading 1484.6% below Wall St target ($5.67)
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.39
Current Trend
Strong Downtrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.85
Wall Street Target
$5.67
(+1484.6%)
Share & Embed Analysis
Last updated: June 03, 2026 5:09 PM ET
Data refreshes hourly during market hours. Next update: 6:09 PM
Data refreshes hourly during market hours. Next update: 6:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1211 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 57 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$253 | 66 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 65 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$219 | 55 HOLD |
